SWOG clinical trial number

SWOG-9428

Evaluation of DNA Ploidy and p53 in Patients Registered to SWOG-8794 and SWOG-9024, Ancillary

Closed

Phase

Accrual

36%

Abbreviated Title

Ancillary

Activated

05/15/1994

Closed

12/01/1999

Research committees

Genitourinary Cancer

Other Clinical Trials

SWOG Clinical Trial Number

S2427

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy after a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)

Research Committee(s)

Genitourinary Cancer

Activated

09/04/2025

Accrual

1%

Open

Phase

SWOG Clinical Trial Number

CCTG-PR26

A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)

Research Committee(s)

Genitourinary Cancer

Activated

01/30/2025

Open

Phase

SWOG Clinical Trial Number

S2312

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature

Research Committee(s)

Genitourinary Cancer

Activated

09/03/2024

Accrual

7%

Open

Phase